Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein(a)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00433823
What this trial is testing

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Who this might be right for
Coronary Heart DiseaseDiabetes MellitusNon-Coronary Atherosclerotic Disease+1 more
Abant Izzet Baysal University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07619118
What this trial is testing

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

Who this might be right for
Hypercholesterolaemia
AstraZeneca 200
Early research (Phase 1)Not Yet RecruitingNCT07722299
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants

Who this might be right for
Hyperlipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00269048
What this trial is testing

SB-480848 In Subjects With Coronary Heart Disease

Who this might be right for
Atherosclerosis
GlaxoSmithKline 969
Early research (Phase 1)Study completedNCT05905068
What this trial is testing

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

Who this might be right for
To Reduce the LDL-C Level in Hypercholesteremia Adult PatientsCombination for Subgroup High LDL-c Patients With Other Comorbidities
Ikaria Bioscience Pty Ltd 32
Early research (Phase 1)Active Not RecruitingNCT05972278
What this trial is testing

Investigating the Effect of Obicetrapib on Lipoprotein Metabolism

Who this might be right for
Lipid Metabolism
NewAmsterdam Pharma 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT07185776
What this trial is testing

HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Fujian Shengdi Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Study completedNCT02098278
What this trial is testing

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

Who this might be right for
Lipoprotein Lipase Deficiency, FamilialHyperlipoproteinemia Type IChylomicronemia, Familial+1 more
Catabasis Pharmaceuticals 13
Early research (Phase 1)UnknownNCT06239714
What this trial is testing

Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hyperlipidemias
Suzhou Sanegene Bio Inc. 64
Post-approval studies (Phase 4)Ended earlyNCT00651014
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 82
Large-scale testing (Phase 3)Study completedNCT01334229
What this trial is testing

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Laval University 22
Not applicableStudy completedNCT05844566
What this trial is testing

OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

Who this might be right for
Acute Coronary SyndromeMyocardial Infarction
Imperial College London 1,139
Not applicableStudy completedNCT02781675
What this trial is testing

The Mediterranean Full-Fat Dairy Study

Who this might be right for
Cardiovascular DiseaseDyslipidemiaInflammation
UCSF Benioff Children's Hospital Oakland 40
Not applicableActive Not RecruitingNCT06157983
What this trial is testing

Evaluation of Cascade Screening for Elevated Lipoprotein(a)

Who this might be right for
Cardiovascular DiseasesDyslipidemiasHereditary Diseases
Karolinska Institutet 1,950
Early research (Phase 1)Study completedNCT01284582
What this trial is testing

Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)

Who this might be right for
HDLDrug Safety
Affiris AG 36
Early research (Phase 1)Study completedNCT02414594
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)

Who this might be right for
Elevated Lipoprotein(a)
Ionis Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableStudy completedNCT03739242
What this trial is testing

Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels

Who this might be right for
Hypercholesterolemia
A. Menarini Industrie Farmaceutiche Riunite S.r.l. 88
Testing effectiveness (Phase 2)Ended earlyNCT01004705
What this trial is testing

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Who this might be right for
Elevated LDL Cholesterol
Ferrer Internacional S.A. 36
Early research (Phase 1)Study completedNCT04774003
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Who this might be right for
Hyperlipidemia
Novartis Pharmaceuticals 40
Next Page